Lyra Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview

Lyra Therapeutics

05/05/2023 19:22

* Lyra Therapeutics Inc  LYRA.OQ   LYRA.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 8
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
 a 97.0% decrease in revenue to $159.5 thousand from $5.37
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lyra Therapeutics
Inc is
for a loss of 36 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Lyra
Therapeutics
Inc is $15​, above​ its last closing price of $2.56. ​​​

This summary was machine generated May 5 at 18:22 GMT.  All
figures in US dollars  unless otherwise stated